Transce3nd’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.6K Buy
+428
New +$23.1K 0.02% 268
2025
Q3
– Sell
-2
Closed -$97 – 349
2025
Q2
$97 Hold
2
– – ﹤0.01% 1188
2025
Q1
$68 Hold
2
– – ﹤0.01% 1168
2024
Q4
$79 Buy
+2
New +$94 ﹤0.01% 1523

Other funds holding CRSP

Transce3nd's CRSP Position: Q3 2026 in Review

Transce3nd opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 428 shares worth $21.6K. The stake represents 0.02% of the portfolio and ranks #268 among its holdings. This is a return to the name: Transce3nd previously reported a position in CRSP as recently as Q2 2025.

Transce3nd first reported a position in CRSP in Q4 2024 and has held it in 4 quarters since. 504 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.

  • Transce3nd held 428 shares of CRISPR Therapeutics worth $21.6K as of Q3 2026.
  • CRISPR Therapeutics was a new Transce3nd position in Q3 2026.
  • CRISPR Therapeutics made up 0.02% of Transce3nd's portfolio in Q3 2026, its #268 holding.
  • Transce3nd first reported a position in CRISPR Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 504 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.

Based on Transce3nd's 13F filing for Q3 2026, filed 26 Oct 2026.